tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ZVRA Stock Latest News

Zevra Therapeutics closes sale of Rare Disease PRV for $150M
The FlyZevra Therapeutics closes sale of Rare Disease PRV for $150M
6d ago
ZVRA
Zevra Therapeutics management to meet with Cantor Fitzgerald
PremiumThe Fly
Zevra Therapeutics management to meet with Cantor Fitzgerald
19d ago
ZVRA
Optimistic Buy Rating for Zevra Therapeutics Driven by Miplyffa Launch and Strategic Financial Moves
PremiumRatings
Optimistic Buy Rating for Zevra Therapeutics Driven by Miplyffa Launch and Strategic Financial Moves
1M ago
ZVRA
Zevra Therapeutics price target raised to $22 from $20 at Guggenheim
PremiumThe Fly
Zevra Therapeutics price target raised to $22 from $20 at Guggenheim
1M ago
ZVRA
Zevra Therapeutics: Promising Outlook with Strong Financials and Strategic Focus on Rare Diseases
PremiumRatings
Zevra Therapeutics: Promising Outlook with Strong Financials and Strategic Focus on Rare Diseases
1M ago
ZVRA
Zevra Therapeutics price target raised to $25 from $23 at Canaccord
PremiumThe FlyZevra Therapeutics price target raised to $25 from $23 at Canaccord
1M ago
ZVRA
Zevra Therapeutics: Strong Buy Rating Backed by Impressive Sales and Robust Financial Position
Premium
Ratings
Zevra Therapeutics: Strong Buy Rating Backed by Impressive Sales and Robust Financial Position
1M ago
ZVRA
Zevra Therapeutics’ Earnings Call Highlights Success and Growth
Premium
Company Announcements
Zevra Therapeutics’ Earnings Call Highlights Success and Growth
1M ago
ZVRA
Zevra Therapeutics price target raised to $18 from $17 at Citizens JMP
PremiumThe Fly
Zevra Therapeutics price target raised to $18 from $17 at Citizens JMP
1M ago
ZVRA
Zevra Therapeutics: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
PremiumRatings
Zevra Therapeutics: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
1M ago
ZVRA
Zevra Therapeutics: Strong Financial Performance and Strategic Growth Justify Buy Rating
PremiumRatings
Zevra Therapeutics: Strong Financial Performance and Strategic Growth Justify Buy Rating
1M ago
ZVRA
Zevra Therapeutics Reports 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
Zevra Therapeutics Reports 2024 Financial Results and Strategic Progress
1M ago
ZVRA
Zevra Therapeutics reports Q4 EPS (67c), consensus (40c)
PremiumThe FlyZevra Therapeutics reports Q4 EPS (67c), consensus (40c)
1M ago
ZVRA
Zevra Therapeutics: Strategic Growth and Financial Strength Drive Buy Rating
Premium
Ratings
Zevra Therapeutics: Strategic Growth and Financial Strength Drive Buy Rating
1M ago
ZVRA
Zevra Therapeutics launches new disease state awareness campaign
Premium
The Fly
Zevra Therapeutics launches new disease state awareness campaign
1M ago
ZVRA
Zevra Therapeutics Sells Priority Review Voucher for $150M
PremiumCompany Announcements
Zevra Therapeutics Sells Priority Review Voucher for $150M
2M ago
8K
ZVRA
Zevra Therapeutics to sell Rare Pediatric Disease PRV for $150M
PremiumThe Fly
Zevra Therapeutics to sell Rare Pediatric Disease PRV for $150M
2M ago
ZVRA
ZVRA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ZVRA Earnings this Week: How Will it Perform?
2M ago
ZVRA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
XLO
ABBV
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
BDRX
FHTX
Zevra Therapeutics price target raised to $21 from $20 at Guggenheim
Premium
The Fly
Zevra Therapeutics price target raised to $21 from $20 at Guggenheim
2M ago
ZVRA
Zevra Therapeutics assumed with an Overweight at Cantor Fitzgerald
Premium
The Fly
Zevra Therapeutics assumed with an Overweight at Cantor Fitzgerald
3M ago
ZVRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >